Decision-making in early breast cancer: Guidelines and decision tools

European Journal of Cancer

Volumn 38, Issue 6, 2002, Pages 745-749

  Baum, M ^a   Ravdin, P M ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Adjuvant therapy; Breast cancer; Decision making; Guidelines

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER PROGRAM; DRUG EFFICACY; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0036212110     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00033-3     Document Type: Article

References (17)

1. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomized trials among 28,896 women
2. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomized trials involving 31 000 recurrences and 24,000 deaths among 75 000 women
3. Polychemotherapy for early breast cancer: An overview of the randomized trials
4. Tamoxifen for early breast cancer: An overview of randomized
5. Adjuvant therapy for breast cancer
6. NCCN practice guidelines for breast cancer
7. Meeting highlights: International consensus panel on the treatment of primary breast cancer
8. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
9. Evaluation of effectiveness: Q-TWiST
10. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
11. Polychemotherapy for early breast cancer: An overview of the randomized clinical trials with quality-adjusted survival analysis
12. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer
13. Mastectomy or lumpectomy? Helping women make informed choices
14. Breast irradiation postlumpectomy: Development and evaluation of a decision instrument
15. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
16. Weighing the risks and benefits of tamoxifen for preventing breast cancer
17. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually